| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/25/1998 | WO1998026797A1 Wound healing formulations containing human plasma fibronectin |
| 06/25/1998 | WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/25/1998 | WO1998026755A1 Cosmetic cleansing and skin care preparation containing plant and algae extracts |
| 06/25/1998 | WO1998026750A2 Use of an extract of gaboon resin |
| 06/25/1998 | WO1998011887A3 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 06/25/1998 | WO1998002151A3 Chemokine receptor antagonists and methods of use therefor |
| 06/25/1998 | CA2275478A1 Piperazine compounds as inhibitors of mmp or tnf |
| 06/25/1998 | CA2275193A1 Method of producing concentrated non-buffered solutions of fibronectin |
| 06/25/1998 | CA2274807A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 06/25/1998 | CA2272101A1 Cosmetic cleansing and skin care preparation containing plant and algae extracts |
| 06/25/1998 | CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/25/1998 | CA2264207A1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 06/24/1998 | EP0848951A1 Use of acetylcysteine for the manufacture of a medicament for the treatment of chronic ulcers |
| 06/24/1998 | EP0848755A1 Vegf-related protein |
| 06/24/1998 | EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 06/24/1998 | EP0848612A2 Use of calendula glycosides for the treatment of psoriasis |
| 06/24/1998 | EP0554363B1 Alteration of rate and character of hair growth |
| 06/24/1998 | CN1185742A Protein kinase c inhibitors |
| 06/24/1998 | CN1185316A Medicinal preparation containing saccharin zinc |
| 06/24/1998 | CA2223742A1 Non-migrating makeup or skin care composition, containing an organopolysiloxane and a fatty phase |
| 06/23/1998 | US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 06/23/1998 | US5770573 CS-1 peptidomimetics, compositions and methods of using the same |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | CA2176506C Substituted oxindoles |
| 06/23/1998 | CA2122271C Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/23/1998 | CA2095721C Gel type compositions having improved oil control |
| 06/20/1998 | CA2225202A1 Compositions for the treatment of chronic wounds |
| 06/18/1998 | WO1998026080A1 Method for expression of heterologous proteins in yeast |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025964A1 Submucosa extracts |
| 06/18/1998 | WO1998025963A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025587A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 06/18/1998 | WO1998025584A2 Cosmetic preparation with a peptide addition |
| 06/18/1998 | WO1998025471A1 A method of biological control |
| 06/18/1998 | WO1998025470A1 A method of biological control |
| 06/18/1998 | WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | DE19653736A1 Kosmetisches Präparat mit Peptidzusatz A cosmetic preparation with additional peptide |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses |
| 06/18/1998 | CA2271919A1 Cosmetic preparation with a peptide addition |
| 06/18/1998 | CA2246306A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 06/17/1998 | EP0847986A1 Esterified hydroxypropylated quaternary ammonium compounds, cosmetic and dermatologic compostions containing them |
| 06/17/1998 | EP0847239A2 Improved method for controlling ectoparasites |
| 06/17/1998 | EP0633765B1 Skin care method and composition |
| 06/17/1998 | CN1184639A Drug for treating lupus erythematosus |
| 06/16/1998 | US5767139 Skin disorders; alopecia; prostate cancer |
| 06/16/1998 | US5767118 4-Heterocyclic peperidines promote release of growth hormone |
| 06/16/1998 | US5767111 18-nor-vitamin D compounds |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders |
| 06/16/1998 | CA2003718C Compounds |
| 06/11/1998 | WO1998024921A1 Syndecan enhancer element and its use for targeting gene expression |
| 06/11/1998 | WO1998024908A1 Human chemokine beta-13 |
| 06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
| 06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
| 06/11/1998 | WO1998024778A1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 06/11/1998 | WO1998024762A1 Vitamin d3 derivatives |
| 06/11/1998 | WO1998024473A1 Tissue fibrosis inhibitor |
| 06/11/1998 | WO1998024465A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | WO1998024436A2 Gel formulations for topical drug delivery |
| 06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | WO1998024418A1 Medicinal composition |
| 06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | CA2277580A1 Human chemokine beta-13 |
| 06/11/1998 | CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/11/1998 | CA2274002A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | CA2273845A1 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | CA2272851A1 Syndecan enhancer element and its use for targeting gene expression |
| 06/11/1998 | CA2272148A1 Vitamin d3 derivatives |
| 06/10/1998 | EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists |
| 06/10/1998 | EP0845992A1 Method of promoting angiogenesis |
| 06/10/1998 | EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 06/10/1998 | EP0845974A1 Compositions containing a peptide cell growth promoter |
| 06/10/1998 | EP0845963A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
| 06/10/1998 | CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 06/10/1998 | CN1184404A Improved method for controlling ectoparasites |
| 06/10/1998 | CN1183958A Freckle dispelling powder |
| 06/10/1998 | CN1183957A Medical liposome ointment |
| 06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
| 06/09/1998 | US5763487 Skin disorders, cardiovascular disorders and cosmetics |
| 06/09/1998 | US5763470 Benzopyran compounds and methods for their use |
| 06/09/1998 | US5763445 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 06/09/1998 | US5763428 Administering active nontoxic derivatives for skin or metabolic disorders |
| 06/09/1998 | US5763426 Dissolving calcipotriol in organic solvent and adding water to the solution to precipitate the hydrate; storage stability; useful for treatment of psoriasis |
| 06/09/1998 | US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions |
| 06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
| 06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |
| 06/09/1998 | US5763214 Fibroblast growth factor 11 |
| 06/09/1998 | US5762912 H2 O-resistant sunscreen/cosmetic compositions comprising hydrophilic acidic species |
| 06/09/1998 | CA2157142C Treatment of diseases caused by sebaceous gland disorders |
| 06/09/1998 | CA2027483C Process for the preparation of an aqueous effervescent solution with emollient action on nail cuticle, composition for said process and corresponding cosmetic treatment |